Login / Signup

Efficacy and safety of 0.05% ingenol mebutate in the treatment of basal cell carcinoma: A prospective study.

Marine VelinNathalie Cardot-LecciaAnne-Claire CathelineauLuc DuteilCatherine Queille-RousselThierry PasseronPhilippe Bahadoran
Published in: Skin health and disease (2022)
Keyphrases
  • basal cell carcinoma
  • combination therapy
  • replacement therapy